Treating cystic fibrosis is the activation of the calcium-activated chloride channel TMEM16A as an alternative route for chloride efflux could be a promising approach.
Cystic fibrosis is a severe hereditary disease of the lung, for which there is currently no cure. The underlying cause of the disease is a malfunction of the chloride channel CFTR, which prevents the secretion of chloride in certain body cells. This leads to dehydration of the mucus layer in the lung.
Cystic Fibrosis
Cystic fibrosis is a genetic disease involving the mucus and sweat glands and the medical world has still to find its cure
Advertisement
‘TMEM16 scramblase, which functions as a lipid transporter and plays an important role in blood coagulation can activate calcium and help in the treatment of cystic fibrosis.’
Tweet it Now
Since TMEM16A is expressed in the same epithelium as CFTR, its activation could restore hydration of the mucus layer. TMEM16A is part of a protein family whose members facilitate the flow of negatively charged chloride ions or lipids across the cell membrane.
Structure of a Chloride Channel Determined
The structure of a TMEM16 scramblase, which functions as a lipid transporter and plays an important role in blood coagulation, was already known from previous work. Researchers of the Department of Biochemistry at the University of Zurich have now also succeeded in decrypting the structure of the chloride channel TMEM16A.
![Respiratory Diseases]( "Respiratory Diseases")
Respiratory diseases affect any part of the respiratory system. Some of the lung diseases like chronic obstructive pulmonary disease can lead to respiratory failure.
To do so, the team led by Professor Raimund Dutzler used cryo-electron microscopy (cryo-EM), a technique whose pioneers were recently awarded the Nobel Prize in Chemistry. "The molecular architecture of this membrane protein is crucial for the targeted development of drugs for treating cystic fibrosis," emphasizes Dutzler.
Discovery of a novel activation mechanism
The chloride channel TMEM16A can be found in different organs of the body and plays a key role in the secretion of chloride in the lung, the contraction of smooth muscles, and the perception of pain. How its structure differs from closely related scramblases of the same family and how the protein is activated by calcium was now revealed through a combination of cryo-EM and electrophysiology.
While its general architecture resembles scramblases of the same family, there are distinct differences in the pore region located in each subunit of the dimeric protein. Scramblases contain a membrane-exposed polar furrow, which allows for the diffusion of lipid headgroups across the lipid bilayer. In contrast, at the same location, TMEM16A forms an hourglass-shaped protein-enclosed channel, which is closed in the absence of calcium.
The binding of positively charged calcium ions in its vicinity opens the channel and allows negatively charged chloride ions to permeate across the membrane.
"This activation mechanism is unique since the bound calcium ions directly change the structure and electrostatics of the ion permeation pore," explains Cristina Paulino, lead author of the study.
Paving the way for novel therapies
The findings that describe the structure and function of TMEM16A pave the way for a mechanistic understanding of this important family of membrane proteins, and they provide a promising template for developing drugs for the treatment of cystic fibrosis.
"Substances leading to the activation of the TMEM16A would compensate the defect in the secretion of chloride ions in the lung," states Raimund Dutzler.
Source: Eurekalert
The structure of a TMEM16 scramblase, which functions as a lipid transporter and plays an important role in blood coagulation, was already known from previous work. Researchers of the Department of Biochemistry at the University of Zurich have now also succeeded in decrypting the structure of the chloride channel TMEM16A.
Respiratory Diseases
Respiratory diseases affect any part of the respiratory system. Some of the lung diseases like chronic obstructive pulmonary disease can lead to respiratory failure.
Advertisement
To do so, the team led by Professor Raimund Dutzler used cryo-electron microscopy (cryo-EM), a technique whose pioneers were recently awarded the Nobel Prize in Chemistry. "The molecular architecture of this membrane protein is crucial for the targeted development of drugs for treating cystic fibrosis," emphasizes Dutzler.
Discovery of a novel activation mechanism
The chloride channel TMEM16A can be found in different organs of the body and plays a key role in the secretion of chloride in the lung, the contraction of smooth muscles, and the perception of pain. How its structure differs from closely related scramblases of the same family and how the protein is activated by calcium was now revealed through a combination of cryo-EM and electrophysiology.
While its general architecture resembles scramblases of the same family, there are distinct differences in the pore region located in each subunit of the dimeric protein. Scramblases contain a membrane-exposed polar furrow, which allows for the diffusion of lipid headgroups across the lipid bilayer. In contrast, at the same location, TMEM16A forms an hourglass-shaped protein-enclosed channel, which is closed in the absence of calcium.
The binding of positively charged calcium ions in its vicinity opens the channel and allows negatively charged chloride ions to permeate across the membrane.
"This activation mechanism is unique since the bound calcium ions directly change the structure and electrostatics of the ion permeation pore," explains Cristina Paulino, lead author of the study.
Paving the way for novel therapies
The findings that describe the structure and function of TMEM16A pave the way for a mechanistic understanding of this important family of membrane proteins, and they provide a promising template for developing drugs for the treatment of cystic fibrosis.
"Substances leading to the activation of the TMEM16A would compensate the defect in the secretion of chloride ions in the lung," states Raimund Dutzler.
Source: Eurekalert
Cystic Fibrosis-Possible Treatment Target Identified
In cystic fibrosis, the compact mucin protein that keeps mucus too thick and sticky, causing constant lung problems is the patients.
Advertisement
Simple Noninvasive Test can Help Personalize Cystic Fibrosis TreatmentPersonalized medications can now be developed by a simple non invasive test for cystic fibrosis found a new study | Advertisement
|
Advertisement
Recommended Readings
Latest Respiratory Disease News
Tuberculosis (TB) is preventable, yet over 10.6 million people were infected with it in 2021. TB is curable, but over 1.6 million people lost their lives to it that same year.
C-PAP-Continuous positive airway pressure used to treat loud snoring, can also diminish heartburn and respiratory complaints.
Imaging has the potential to assist in identifying the appropriate antibiotics for treating different lung infections, including pneumonia and cystic fibrosis
New study compared the effect of different types of exercise in improving lung function in adult patients with asthma using Network Meta-analysis.
Adenovirus infection is tied to severe blood clotting disorders like thrombocytopenia, a new study reveals.
